<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "rasburicase inj VIAL">
<dose><value>0.1 - 0.2</value>
<value>0.15 - 0.2</value>
<value>0.2</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>1.5 mg</value>
</strength>
<frequency><value>DAILY</value>
<value>BID</value>
</frequency>
<instruction><value>for 3 days.</value>
</instruction>
<volume></volume>
<units><value>mg/kg</value>
<value>mg/kg/day</value>
</units>
<Population><value>ADULT. Hyperuricemia.</value>
<value>CHILDREN, over 1 month of age. Tumor Lysis Syndrome</value>
<value>ADULT. Hyperuricemia in cancer patients.</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Treatment up to 7 days.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=1983</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Enzymes</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>